广誉远(600771)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

600771 广誉远

午间休市 08-14 11:29:54

{"stockData":{"symbol":"600771","market":"SH","secType":"STK","nameCN":"广誉远","latestPrice":14.13,"timestamp":1786678194000,"preClose":14.31,"halted":0,"volume":8302201,"delay":0,"changeRate":-0.0126,"floatShares":488999999,"shares":488999999,"eps":0.1353,"marketStatus":"午间休市","change":-0.18,"latestTime":"08-14 11:29:54","open":14.4,"high":14.52,"low":14.05,"amount":119000000,"amplitude":0.0328,"askPrice":14.14,"askSize":89,"bidPrice":14.13,"bidSize":54,"shortable":0,"etf":0,"ttmEps":0.1353,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786683600000},"marketStatusCode":3,"adr":0,"adjPreClose":14.31,"symbolType":"stock","openAndCloseTimeList":[[1786671000000,1786678200000],[1786683600000,1786690800000]],"highLimit":15.74,"lowLimit":12.88,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":489491141,"isCdr":false,"pbRate":4.12,"roa":"--","peRate":104.43459,"roe":"4.01%","epsLYR":0.13,"committee":0.16319,"marketValue":6917000000,"turnoverRate":0.017,"status":1,"floatMarketCap":6917000000},"requestUrl":"/m/hq/s/600771","defaultTab":"news","newsList":[{"id":"2658730389","title":"广誉远：半夏泻心汤颗粒定价综合考量多重因素","url":"https://stock-news.laohu8.com/highlight/detail?id=2658730389","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658730389?lang=zh_cn&edition=full","pubTime":"2026-08-12 17:36","pubTimestamp":1786527367,"startTime":"0","endTime":"0","summary":"半夏泻心汤颗粒是按古代经典名方目录管理的中药复方制剂药品而非传统饮片，公司产品定价综合考量产品组方原料、质量标准、生产质控、市场环境及患者用药可及性等多重因素，始终以产品临床价值与长期市场发展为导向，不存在单纯追求高端高价作为产品定位。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200030392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600771","BK0077","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658996429","title":"广誉远：已建立多维度常态化管控机制","url":"https://stock-news.laohu8.com/highlight/detail?id=2658996429","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658996429?lang=zh_cn&edition=full","pubTime":"2026-08-11 17:30","pubTimestamp":1786440631,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远08月11日在投资者关系平台上答复投资者关心的问题。首先，公司始终高度重视终端合规经营与品牌声誉管理，已建立多维度常态化管控机制，持续规范经销商经营商业推广宣传行为，保护品牌声誉。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100028086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600771","BK0077","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657596146","title":"股市必读：广誉远（600771）8月6日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2657596146","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657596146?lang=zh_cn&edition=full","pubTime":"2026-08-07 01:21","pubTimestamp":1786036870,"startTime":"0","endTime":"0","summary":"截至2026年8月6日收盘，广誉远报收于14.14元，下跌1.6%，换手率1.81%，成交量8.88万手，成交额1.26亿元。董秘最新回复投资者： 目前白酒拥有十二项国标香型，董香型以草本参与制曲为核心特征。恳请管理层对该定位方案予以研讨。龟龄集酒炮制所用原药粉是依托国家级非物质文化遗产升炼技艺打造，公司持续探索产品差异化品牌定位与市场传播路径，推进养生酒业务发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700001587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0077","BK0239","600771"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655890876","title":"股市必读：广誉远（600771）7月29日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2655890876","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655890876?lang=zh_cn&edition=full","pubTime":"2026-07-30 01:29","pubTimestamp":1785346150,"startTime":"0","endTime":"0","summary":"截至2026年7月29日收盘，广誉远报收于14.64元，上涨2.45%，换手率1.65%，成交量8.06万手，成交额1.17亿元。董秘最新回复投资者： 董秘您好。控股股东依法行使权利、履行义务，保证上市公司独立性，保障经营层充分履职。投资者： 董秘您好，7月15日前公司未披露半年报业绩预告，结合一季报业绩推算预示二季度盈利环比承压。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073000000816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","BK0188","600771"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655127865","title":"广誉远：公司将结合自身发展实际持续深化终端精细化运营","url":"https://stock-news.laohu8.com/highlight/detail?id=2655127865","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655127865?lang=zh_cn&edition=full","pubTime":"2026-07-29 17:51","pubTimestamp":1785318670,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远07月29日在投资者关系平台上答复投资者关心的问题。下半年传统旺季来临，公司对于国药堂门店动销、龟龄集酒渠道拓展有哪些落地举措提振经营？公司将结合自身发展实际持续深化终端精细化运营，提升门店经营质效。龟龄集酒线上线下协同运营，全力推动业务持续深耕。根据已披露定期报告信息，龟龄集酒业务占整体营收比重较小，后续发展情况请以公司官方信息为准，注意投资风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900029759.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","BK0188","600771"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655637658","title":"广誉远：公司持续推进经营管理团队补强工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2655637658","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655637658?lang=zh_cn&edition=full","pubTime":"2026-07-29 17:33","pubTimestamp":1785317608,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远07月29日在投资者关系平台上答复投资者关心的问题。公司持续推进经营管理团队补强工作，完善管理团队，相关事项正在推进中。控股股东依法行使权利、履行义务，保证上市公司独立性，保障经营层充分履职。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900029178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0077","600771","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654052280","title":"每周股票复盘：广誉远（600771）拟用公积弥补亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=2654052280","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654052280?lang=zh_cn&edition=full","pubTime":"2026-07-26 01:46","pubTimestamp":1785001573,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，广誉远报收于13.94元，较上周的15.04元下跌7.31%。本周，广誉远7月20日盘中最高价报15.29元。广誉远当前最新总市值68.24亿元，在中药板块市值排名28/66，在两市A股市值排名2303/5200。本周关注点公司公告汇总：广誉远拟使用母公司资本公积金728,341,393.03元弥补累计亏损。本次弥补亏损后，资本公积金将减少至2,121,063,674.59元，未分配利润为0元。公司依据相关规定通知债权人，债权人可在规定期限内申报债权，要求清偿债务或提供担保。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000363.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600771","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653038135","title":"广誉远（600771）披露使用公积金弥补亏损通知债权人的公告，7月24日股价下跌4.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653038135","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653038135?lang=zh_cn&edition=full","pubTime":"2026-07-24 22:15","pubTimestamp":1784902504,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，广誉远报收于13.94元，较前一交易日下跌4.06%，最新总市值为68.24亿元。近日，广誉远中药股份有限公司发布《关于使用公积金弥补亏损通知债权人的公告》。公告显示，公司于2026年4月21日和6月29日分别召开第九届董事会第三次会议及2025年年度股东会，审议通过使用母公司资本公积金728,341,393.03元弥补累计亏损的议案。公司依据相关规定通知债权人，债权人可在规定期限内申报债权，要求清偿债务或提供担保。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400041891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600771","BK0077","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653762802","title":"股市必读：广誉远（600771）7月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2653762802","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653762802?lang=zh_cn&edition=full","pubTime":"2026-07-23 01:15","pubTimestamp":1784740545,"startTime":"0","endTime":"0","summary":"截至2026年7月22日收盘，广誉远报收于14.67元，下跌0.81%，换手率2.4%，成交量11.77万手，成交额1.73亿元。广誉远近日对龟龄集也进行了提价，请问为何没有发布公告。公司严格遵守信息披露公平性原则，始终按照监管规则履行信息披露义务，所有达到法定披露标准的重大信息均通过指定信息披露渠道统一向全体投资者公开。公司重大诉讼进展公告均以法院正式法律文书或有效通知为客观依据，不存在应当披露而未披露或披露滞后的情形。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300001326.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0188","600771","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653575641","title":"广誉远：公司严格遵守信息披露公平性原则","url":"https://stock-news.laohu8.com/highlight/detail?id=2653575641","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653575641?lang=zh_cn&edition=full","pubTime":"2026-07-22 17:48","pubTimestamp":1784713704,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远07月22日在投资者关系平台上答复投资者关心的问题。龟龄集是公司营收、毛利第一大单品，本次调价契合中医药优质优价政策，却仅对内通知渠道，散户只能从经销商处零散获取消息，信息披露有失公平。公司严格遵守信息披露公平性原则，始终按照监管规则履行信息披露义务，所有达到法定披露标准的重大信息均通过指定信息披露渠道统一向全体投资者公开。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200036609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","600771","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653756410","title":"广誉远：个别药品品规在部分渠道的价格调整是公司的日常经营范畴","url":"https://stock-news.laohu8.com/highlight/detail?id=2653756410","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653756410?lang=zh_cn&edition=full","pubTime":"2026-07-22 17:45","pubTimestamp":1784713511,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远07月22日在投资者关系平台上答复投资者关心的问题。广誉远近日对龟龄集也进行了提价，请问为何没有发布公告。公司始终严格遵照监管要求履行信息披露义务，对个别药品品规在部分渠道的价格进行调整是公司的日常经营范畴，不涉及应披未披及其他违反监管规则的情形。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200036474.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600771","BK0239","BK0188","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652783237","title":"每周股票复盘：广誉远（600771）涉9.34亿元诉讼上诉已受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2652783237","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652783237?lang=zh_cn&edition=full","pubTime":"2026-07-19 01:52","pubTimestamp":1784397133,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，广誉远报收于15.04元，较上周的14.23元上涨5.69%。本周，广誉远7月16日盘中最高价报16.03元。本周关注点公司公告汇总：广誉远因业绩承诺补偿纠纷上诉，涉案金额933,591,035.11元及利息，陕西省高院已受理。公司公告汇总广誉远中药股份有限公司因不服西安市中级人民法院关于业绩承诺补偿纠纷的一审判决，已提起上诉，请求判令对方支付补偿款利息及诉讼费用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600771","BK0077","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651897184","title":"股市必读：广誉远（600771）7月14日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2651897184","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651897184?lang=zh_cn&edition=full","pubTime":"2026-07-15 04:27","pubTimestamp":1784060829,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，广誉远报收于15.1元，上涨0.33%，换手率3.27%，成交量16.03万手，成交额2.43亿元。董秘最新回复投资者： 当前整体消费环境偏弱，公司 7 月 1 日上调普通款龟龄集胶囊建议零售价，同时回收渠道全部低价库存。当日关注点交易信息汇总：7月14日主力资金净流出60.31万元，游资资金净流入1300.23万元。公司公告汇总：广誉远就业绩承诺补偿纠纷提起上诉，涉案金额933,591,035.11元及利息，陕西省高级人民法院已受理。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500005970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600771","BK0077","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651179123","title":"广誉远（600771）披露重大诉讼进展公告，7月14日股价上涨0.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651179123","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651179123?lang=zh_cn&edition=full","pubTime":"2026-07-14 17:32","pubTimestamp":1784021542,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，广誉远报收于15.1元，较前一交易日上涨0.33%，最新总市值为73.91亿元。该股当日开盘14.84元，最高15.44元，最低14.65元，成交额达2.43亿元，换手率为3.27%。近日，广誉远中药股份有限公司发布《关于重大诉讼的进展公告》。陕西省高级人民法院已受理该上诉案件。涉案金额合计933,591,035.11元及利息。公告指出，案件不会对公司损益产生负面影响，但最终影响以法院生效裁判为准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400033949.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600771","BK0188","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651173989","title":"广誉远：公司核心产品遵循古法工艺，生产炮制周期较长","url":"https://stock-news.laohu8.com/highlight/detail?id=2651173989","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651173989?lang=zh_cn&edition=full","pubTime":"2026-07-14 16:03","pubTimestamp":1784016200,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远07月14日在投资者关系平台上答复投资者关心的问题。公司核心产品遵循古法工艺，生产炮制周期较长，从未对公司生产经营造成影响。公司近年来存货增长主要为贵细药材及在产品的战略性前置储备，是保障产品品质与长期供应的基础，不会对公司日常经营造成负面影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400029373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","BK0188","600771"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651173602","title":"广誉远：酒剂车间设备更新提升自动化智能化水平","url":"https://stock-news.laohu8.com/highlight/detail?id=2651173602","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651173602?lang=zh_cn&edition=full","pubTime":"2026-07-14 16:03","pubTimestamp":1784016200,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远(600771)07月14日在投资者关系平台上答复投资者关心的问题。投资者提问：公司酒剂设备大规模采购，是现有产能停产了吗？是增加产能吗？广誉远回复：您好，感谢您的关注。公司现有酒类产品生产线正常运营，不存在停产情形。本次酒剂车间设备更新是公司践行“提质增效重回报”行动方案，基于统筹推进生产设备智能升级改造，促进生产提质增效，提升自动化、智能化水平，夯实经营质量根基，做好产能提升储备，增强供应链保障能力的举措之一。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400029374.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0188","600771"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649675621","title":"股市必读：广誉远（600771）7月6日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2649675621","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649675621?lang=zh_cn&edition=full","pubTime":"2026-07-07 01:42","pubTimestamp":1783359733,"startTime":"0","endTime":"0","summary":"截至2026年7月6日收盘，广誉远报收于14.26元，上涨0.92%，换手率1.99%，成交量9.73万手，成交额1.39亿元。本次调价预计对公司全年毛利率、净利润带来多大影响，为何未第一时间通过法定披露渠道向全体投资者公开？公司严格遵守信息披露公平性原则，不存在应披未披及其他违反监管规则的情形。2026年度毛利率、净利润等公司相关经营成果请关注后续的定期报告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070700000821.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0077","600771","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649464456","title":"广誉远：公司严格遵守信息披露公平性原则","url":"https://stock-news.laohu8.com/highlight/detail?id=2649464456","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649464456?lang=zh_cn&edition=full","pubTime":"2026-07-06 15:51","pubTimestamp":1783324270,"startTime":"0","endTime":"0","summary":"本次调价预计对公司全年毛利率、净利润带来多大影响，为何未第一时间通过法定披露渠道向全体投资者公开？公司严格遵守信息披露公平性原则，不存在应披未披及其他违反监管规则的情形。2026年度毛利率、净利润等公司相关经营成果请关注后续的定期报告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600017902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0188","BK0239","600771"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648651476","title":"广誉远：本次股东会已通过《关于使用公积金弥补亏损的议案》","url":"https://stock-news.laohu8.com/highlight/detail?id=2648651476","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648651476?lang=zh_cn&edition=full","pubTime":"2026-07-03 15:54","pubTimestamp":1783065265,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远07月03日在投资者关系平台上答复投资者关心的问题。投资者提问：本次年度股东大会表决结果显示，在持股 5% 以下的中小股东投票中，董事薪酬方案获反对票比例达 52.95%，同时 2025 年度利润分配预案、计提信用及资产减值损失议案的反对票比例均超 40%，集中反映出中小股东对管理层履职成效、公司分红安排、历史应收账款清收工作存在较多关切。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300026143.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600771","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648323651","title":"广誉远：公司已围绕“科技创新”主线","url":"https://stock-news.laohu8.com/highlight/detail?id=2648323651","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648323651?lang=zh_cn&edition=full","pubTime":"2026-07-03 15:37","pubTimestamp":1783064268,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远07月03日在投资者关系平台上答复投资者关心的问题。公司已围绕“科技创新”主线，结合行业环境、市场变化及实际发展情况在内部制定了相应量化目标。公司将严格按照规划方向稳步推进各项经营举措，全力推动营收与盈利持续改善，相关经营成果会在定期报告中及时披露，敬请广大投资者关注公司官方公告及定期报告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300023555.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0188","600771","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786681308526,"stockEarnings":[{"period":"1week","weight":0.012},{"period":"1month","weight":-0.0523},{"period":"3month","weight":-0.1084},{"period":"6month","weight":-0.1929},{"period":"1year","weight":-0.3288},{"period":"ytd","weight":-0.2041}],"compareEarnings":[{"period":"1week","weight":0.0068},{"period":"1month","weight":-0.0101},{"period":"3month","weight":-0.0504},{"period":"6month","weight":-0.038},{"period":"1year","weight":0.0661},{"period":"ytd","weight":-0.0106}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广誉远中药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"65920人(较上一季度增加2.20%)","perCapita":"7425股","listingDate":"1996-11-05","address":"山西省晋中市太谷区广誉远路1号","registeredCapital":"48949万元","survey":"　　广誉远中药股份有限公司的主营业务是中药产品的生产与销售。公司的主要产品是龟龄集、定坤丹大蜜丸、定坤丹水蜜丸、定坤丹口服液、安宫牛黄丸、牛黄清心丸、加味龟龄集酒、远字牌龟龄集酒。公司产品先后获得“山西精品”认定，六味地黄丸传统制作技艺及姜炭制作技艺入选晋中市非物质文化遗产名录。","listedPrice":4.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"广誉远(600771)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供广誉远(600771)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"广誉远,600771,广誉远股票,广誉远股票老虎,广誉远股票老虎国际,广誉远行情,广誉远股票行情,广誉远股价,广誉远股市,广誉远股票价格,广誉远股票交易,广誉远股票购买,广誉远股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"广誉远(600771)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供广誉远(600771)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}